HIV Protease Inhibitors and Hyperlipidemia
- 1 January 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (1) , 7-9
- https://doi.org/10.1161/01.ATV.0000198749.28422.29
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Ritonavir Impairs Lipoprotein Lipase–Mediated Lipolysis and Decreases Uptake of Fatty Acids in Adipose TissueArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Impact of Treatment With Protease Inhibitors on Aortic Stiffness in Adult Patients With Human Immunodeficiency Virus InfectionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearanceJournal of Lipid Research, 2005
- Postprandial Lipoprotein Changes in Patients Taking Antiretroviral Therapy for HIV InfectionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individualsAtherosclerosis, 2005
- HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the NucleusJournal of Biological Chemistry, 2001
- Involvement of Membrane-Associated Proteins in the Acute Regulation of Cellular Fatty Acid UptakeJournal of Molecular Neuroscience, 2001
- Role of CD36 in Membrane Transport and Utilization of Long-Chain Fatty Acids by Different TissuesJournal of Molecular Neuroscience, 2001
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998